Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 26993499)

Published in Cancer Immunol Immunother on March 18, 2016

Authors

Pauline M W van Kempen1, Rob Noorlag2, Justin E Swartz3, Niels Bovenschen4,5, Weibel W Braunius3,6, Jeroen F Vermeulen4, Ellen M Van Cann6, Wilko Grolman3, Stefan M Willems4,5

Author Affiliations

1: Department of Otorhinolaryngology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. p.m.w.vankempen-2@umcutrecht.nl.
2: Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
3: Department of Otorhinolaryngology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
4: Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
5: Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
6: Department of Head and Neck Surgical Oncology, Cancer Center University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Articles citing this

Cancer and physical activity. J Oral Maxillofac Pathol (2017) 0.75

Articles cited by this

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

The molecular biology of head and neck cancer. Nat Rev Cancer (2010) 9.84

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res (2011) 9.03

HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 6.53

Validation of tissue microarray technology in breast carcinoma. Lab Invest (2000) 5.50

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81

No consent should be needed for using leftover body material for scientific purposes. For. BMJ (2002) 3.77

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol (2012) 3.04

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62

PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res (2012) 2.43

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys (2009) 2.26

Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol (2002) 2.04

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res (2014) 1.86

SerpinB1 protects the mature neutrophil reserve in the bone marrow. J Leukoc Biol (2011) 1.60

Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol (1998) 1.59

Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol (2012) 1.45

Granzymes in cancer and immunity. Cell Death Differ (2010) 1.44

The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J Exp Med (2007) 1.37

Perforin: structure, function, and role in human immunopathology. Immunol Rev (2010) 1.30

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer (2013) 1.30

Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer (2013) 1.28

Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One (2012) 1.21

Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer (2014) 1.20

The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol (2001) 1.19

Immune suppression in head and neck cancers: a review. Clin Dev Immunol (2011) 1.17

CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer (2013) 1.13

Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma. Clin Cancer Res (2005) 1.11

The orphan granzymes of humans and mice. Curr Opin Immunol (2003) 1.09

Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer. Laryngoscope (2012) 1.09

Orphan granzymes find a home. Immunol Rev (2010) 1.05

Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol (1995) 1.03

Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma. Oral Oncol (2009) 1.02

Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J (2007) 1.02

CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis. Int J Cancer (2012) 0.99

Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics (2013) 0.96

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood (2006) 0.95

Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch (2014) 0.91

Melanoma Treatments: Advances and Mechanisms. J Cell Physiol (2015) 0.88

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation. Cancer Med (2014) 0.87

Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death. PLoS One (2011) 0.86

Anatomy of a murder: how cytotoxic T cells and NK cells are activated, develop, and eliminate their targets. Immunol Rev (2010) 0.85

Identification of SERPINB1 as a physiological inhibitor of human granzyme H. J Immunol (2012) 0.85

Correlation of serpin-protease expression by comparative analysis of real-time PCR profiling data. Genomics (2006) 0.79